Daily Anesthesiology Research Analysis
Analyzed 71 papers and selected 3 impactful papers.
Summary
The three most impactful papers were a randomized-trial meta-analysis showing that intraoperative hemoadsorption does not clearly reduce cardiac surgery-associated acute kidney injury, a large cohort study proposing a simplified coagulation-centered sepsis-induced coagulopathy score, and an anatomical investigation that challenges the presumed pericapsular mechanism of the PENG block. Together, they provide clinically important negative evidence, improve risk stratification, and refine the mechanistic basis of regional anesthesia.
Research Themes
- Evidence-based reassessment of perioperative interventions
- Simplification and mechanistic refinement of critical-care definitions
- Anatomical validation of regional anesthesia mechanisms
Selected Articles
1. Intraoperative hemoadsorption and cardiac surgery-associated acute kidney injury: an updated systematic review and meta-analysis with trial sequential analysis.
This updated systematic review included 15 randomized controlled trials and found that intraoperative hemoadsorption was not associated with a statistically significant reduction in cardiac surgery-associated acute kidney injury (RR 0.80, 95% CI 0.63-1.03; P=0.08). No convincing improvement was demonstrated for mortality, renal replacement therapy, mechanical ventilation, or length of stay, and trial sequential analysis indicated that the evidence remains insufficient.
Impact: The study provides an important negative result against increasing adoption of an expensive and biologically plausible intervention without proven patient benefit. Its use of trial sequential analysis strengthens the interpretation that current evidence does not justify routine intraoperative hemoadsorption.
Clinical Implications: Routine intraoperative hemoadsorption should not be adopted solely to prevent cardiac surgery-associated acute kidney injury. Clinicians and institutions should consider the uncertain benefit, costs, device-related risks, and opportunity costs while awaiting adequately powered multicenter randomized trials.
Key Findings
- Fifteen randomized controlled trials were included; nine trials reporting cardiac surgery-associated acute kidney injury comprised 947 patients.
- Hemoadsorption did not significantly reduce cardiac surgery-associated acute kidney injury compared with standard care (RR 0.80, 95% CI 0.63-1.03; P=0.08).
- The evidence was judged very low certainty, and trial sequential analysis indicated that definitive conclusions require larger randomized trials.
Methodological Strengths
- Systematic review and meta-analysis focused exclusively on randomized controlled trials and followed PRISMA methods.
- Trial sequential analysis, subgroup analyses, and sensitivity analyses were used to assess robustness and information size.
Limitations
- The included trials were heterogeneous and the overall certainty of evidence was very low.
- The analysis may have been underpowered for severe acute kidney injury and other less frequent clinical outcomes.
Future Directions: Future research should prioritize large, multicenter randomized trials with standardized hemoadsorption protocols, biologically relevant timing, clinically meaningful kidney outcomes, mortality, and cost-effectiveness endpoints.
BACKGROUND: Cardiac surgery-associated acute kidney injury (CSA-AKI) following cardiopulmonary bypass (CPB) remains a high-risk complication with limited effective management. Hemoadsorption is increasingly used as an adjunctive therapy due to its potent cytokines clearance in experimental settings, yet its clinical efficacy is debated. This study aimed to evaluate the effect of hemoadsorption versus standard care on CSA-AKI and other major outcomes in adult cardiac surgery patients. METHODS: An updated systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted following PRISMA guidelines. PubMed, Medline, Embase, Web of Science, and the Cochrane Library were systematically searched from inception to 8 February 2025.
2. Proposal of simplified sepsis-induced coagulopathy criteria (SIC-2) for the detection of early-phase disseminated intravascular coagulation in sepsis.
In 18,086 patients with sepsis from MIMIC-IV, the simplified SIC-2 criteria, which remove the SOFA component, showed discrimination for overt disseminated intravascular coagulation comparable to the original SIC (AUC 0.854 vs. 0.850). Although the original SIC had slightly better discrimination for 28-day mortality, the absolute difference was small, supporting SIC-2 as a coagulation-centered screening phenotype rather than a general severity score.
Impact: This study challenges the assumption that a global organ dysfunction score must be embedded in a coagulation-specific definition. A simpler score could improve interpretability, bedside calculation, and phenotype consistency across sepsis studies and clinical pathways.
Clinical Implications: SIC-2 may be considered as a candidate screening tool for early sepsis-associated coagulopathy and progression to overt disseminated intravascular coagulation. It should not yet replace established criteria in guidelines without prospective external validation and assessment of treatment-guiding utility.
Key Findings
- The study analyzed 18,086 patients with sepsis from the MIMIC-IV database.
- SIC-2 showed discrimination for overt disseminated intravascular coagulation comparable to the original SIC (AUC 0.854 vs. 0.850; P=0.37).
- Removing SOFA caused only a small reduction in 28-day mortality discrimination (AUC 0.614 vs. 0.621), while improving conceptual focus on coagulation biology.
Methodological Strengths
- Large cohort size with non-inferiority comparison of the original and simplified definitions.
- Evaluation included discrimination, calibration, mortality, disseminated intravascular coagulation, and organ-support-free outcomes.
Limitations
- The retrospective analysis used a single critical-care database and may have limited external generalizability.
- SIC-2 was not prospectively validated and its effect on treatment decisions or patient outcomes remains uncertain.
Future Directions: Prospective multicenter validation should assess SIC-2 across different healthcare systems, sepsis phenotypes, and laboratory platforms, while determining whether it improves early anticoagulation, transfusion, or organ-support decisions.
BACKGROUND: Sepsis-induced coagulopathy (SIC) was introduced to identify early coagulation abnormalities in sepsis and to predict progression to overt disseminated intravascular coagulation (DIC). However, inclusion of the SOFA may conflate coagulation-specific biology with overall illness severity. OBJECTIVES: To evaluate whether removal of the SOFA component preserves the diagnostic and prognostic performance of SIC and to determine whether a simplified coagulation-centered construct (SIC-2) maintains clinical utility. METHODS: In a retrospective cohort of 18,086 patients with sepsis from the MIMIC-IV database, we compared original SIC and SIC-2 using a non-inferiority framework. Predictive performance for overt DIC within 5 ICU days, 28-day mortality, and organ-support-free outcomes was evaluated for both discrimination and calibration using the area under the receiver operating characteristic curve (AUC) and calibration slopes.
3. Anatomic basis of the PENG block: dissection, cryo-cross-sections, and histology challenge a pericapsular target.
Using ultrasound-guided injections in 10 cryopreserved cadavers, followed by dissection, cryo-cross-sectional analysis, and histology, this study found that PENG-block injectate was predominantly localized within the iliopsoas muscle compartment rather than consistently around the hip capsule. Small intramuscular nerve branches and potential femoral nerve involvement may contribute to analgesia, challenging the original pericapsular target concept.
Impact: This is a mechanistically important anatomical study that revises the presumed target of a widely used regional anesthesia technique. Clarifying the true injectate distribution may improve block teaching, safety assessment, local anesthetic dosing, and interpretation of clinical efficacy.
Clinical Implications: Clinicians should avoid assuming that PENG block selectively deposits local anesthetic around the hip capsule or obturator nerve. Potential femoral nerve involvement and intramuscular spread should be considered when planning the block, interpreting quadriceps weakness, and selecting patients and doses.
Key Findings
- In 10 cryopreserved cadavers, injectate was predominantly subepimysial and intramuscular within the iliopsoas compartment.
- The hip capsule was not consistently involved, and the obturator nerve was not stained in gross dissection.
- Small intramuscular nerve branches and staining near the femoral nerve suggest mechanisms other than selective pericapsular or obturator nerve blockade may contribute to analgesia.
Methodological Strengths
- The study combined ultrasound-guided procedural replication with gross dissection, cryo-cross-sectional imaging, and histology.
- Use of anatomical and microscopic methods allowed direct assessment of injectate localization and nearby neural structures.
Limitations
- The study used only 10 cadavers, limiting statistical precision and anatomical generalizability.
- Cadaveric tissue properties and marker dispersion may not fully reproduce injectate spread in living patients.
Future Directions: Future studies should combine dynamic imaging in living patients with dose- and volume-dependent spread analysis, quantitative assessment of femoral nerve involvement, and clinical correlation with analgesia and quadriceps motor function.
BACKGROUND: The pericapsular nerve group (PENG) block was developed to result in local anesthetic (LA) spread in the plane between the iliopubic ramus and the iliacus muscle. We aimed to investigate the anatomical and histological basis of injectate spread following a PENG block. METHODS: We performed a PENG block in 10 cryopreserved cadavers under ultrasound guidance. A 22-gage, 50 mm needle was inserted using an in-plane approach. After contacting the bone at the target site, 20 mL of the solution mixed with the marker (methylene blue or heparinized erythrocytes) was injected. The dispersion of the injectate was analyzed using anatomical dissection, cryo-cross-sections, and microscopy. RESULTS: Gross anatomical dissection demonstrated methylene blue staining in close proximity to the femoral nerve and its branches, without staining of the obturator nerve. Cryo-cross-sectional and histological analyses showed predominantly subepimysial and intramuscular localization of the injectate within the iliopsoas muscle compartment, without consistent involvement of the hip capsule.